Profil
Wilhelm Krek is the founder of TOLREMO therapeutics AG, founded in 2017.
Dr. Krek is also the founder of Proteomedix AG.
Former job at Dana-Farber Cancer Institute, Inc. as Principal.
Former job at Friedrich Miescher Institute as Principal.
Ehemalige bekannte Positionen von Wilhelm Krek
| Unternehmen | Position | Ende |
|---|---|---|
Proteomedix AG
Proteomedix AG BiotechnologyHealth Technology Operates as a private, commercial-stage diagnostics oncology company | Gründer | 29.08.2018 |
TOLREMO therapeutics AG
TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services Develops and delivers therapies for treating cancer patients | Gründer | - |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Corporate Officer/Principal | - |
Friedrich Miescher Institute
Friedrich Miescher Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
Friedrich Miescher Institute
Friedrich Miescher Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteomedix AG
Proteomedix AG BiotechnologyHealth Technology Operates as a private, commercial-stage diagnostics oncology company | Health Technology |
TOLREMO therapeutics AG
TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services Develops and delivers therapies for treating cancer patients | Commercial Services |
















